These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease. Guyton RA Ann Thorac Surg; 2006 Jun; 81(6):1949-57. PubMed ID: 16731112 [TBL] [Abstract][Full Text] [Related]
30. Angioscopic findings after drug-eluting stent implantation. Takano M; Mizuno K Herz; 2007 Jun; 32(4):281-6. PubMed ID: 17607534 [TBL] [Abstract][Full Text] [Related]
31. Regulatory issues facing the development of drug-eluting stents: a US FDA perspective. Boam AB Expert Rev Med Devices; 2006 May; 3(3):297-300. PubMed ID: 16681451 [TBL] [Abstract][Full Text] [Related]
32. Arterial stents as a therapeutic platform. Roitberg B Surg Neurol; 2003 Mar; 59(3):146-7. PubMed ID: 12693402 [No Abstract] [Full Text] [Related]
33. A meta-analysis of the effect of thiazolidinediones on in-stent restenosis after coronary stent implantation. Chen L; Tonkin A Am Heart J; 2007 Nov; 154(5):e41; author reply e43. PubMed ID: 17967579 [No Abstract] [Full Text] [Related]
34. Sirolimus PK trial: a pharmacokinetic study of the sirolimus-eluting Bx velocity stent in patients with de novo coronary lesions. Vetrovec GW; Rizik D; Williard C; Snead D; Piotrovski V; Kopia G Catheter Cardiovasc Interv; 2006 Jan; 67(1):32-7. PubMed ID: 16342216 [TBL] [Abstract][Full Text] [Related]
35. [Drug-eluting stents: breakthrough or time bomb]. Lüscher TF; Silber S Herz; 2007 Jun; 32(4):265-7. PubMed ID: 17607531 [No Abstract] [Full Text] [Related]